Details for 2020900848

Up to date per 04.04.2026

Actions

Title / Product Name

LEVOSIMENDAN ZUM BEHANDELN DER PULMONALEN HYPERTENSION BEI HERZINSUFFIZIENZ MIT ERHALTENER AUSWURFFRAKTION (PH-HF-PEF)

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2020900848

EP Publication Number

4076398

E-Number

1887315

Language

PCT Number

US20065166

Publication Date

26.10.2022 A

18.02.2026 B1

Registration Date

18.02.2026

AT Publication Date

15.03.2026

Application Date

15.12.2020

Registration Number

Priorities

16.12.2019

201962948735 P

30.01.2020

202062967920 P

12.03.2020

202062988720 P

02.06.2020

202063033773 P

12.08.2020

202063064671 P

IPC

A61K 31/216 20060101AFI20250902BHEP

Maximum Duration of Protection

15.12.2040

Owner

Tenax Therapeutics, Inc.One Copley Parkway, Suite 490 Morrisville, NC 27560US

Representative

No representatives present

Inventor

RANDALL, DouglasC/o Tenax Therapeutics, Inc. 1 Copley Parkway, Suite 490 Morrisville, NC 27560US

HAY, Douglas497 Geigel Hill Road Ottsville, PA 18942US

RICH, Stuart Skokie, IL 60076US

Information about Fees